Résultats de la recherche - 86 results
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
effectiveness (VE) in participating European countries since early 2021.AimWe aimed to measure VE against PCR-confirmed SARS-CoV-2 in patients ≥ 20 years hospitalised with severe acute respiratory infection ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
SARS-CoV-2 in hospitalised severe acute respiratory illness (SARI) patients ≥ 20 years, combining data from these networks during Alpha (March-June)- and Delta (June-December)-dominant periods, ...
Aetiological and prognostic roles of frailty, multimorbidity and socioeconomic characteristics in the development of SARS-CoV-2 health outcomes: protocol for systematic reviews of population-based studies
infection probability, hospitalisation, intensive care unit (ICU) admission, mechanical ventilation and COVID-19 related mortality among general population and (2) to investigate the prognostic roles of ...
Surveillance épidémiologique de la rougeole (Morbillivirus)- 2022
contamination en Belgique. Les autres cas de rougeole étaient des cas isolés dont la source de contamination n’est pas connue. • Pour un des 8 cas aigus enregistrés, une hospitalisation s’est avérée nécessaire. ...
A comparison of COVID-19 incidence rates across six European countries in 2021.
such as death or hospitalisation will be important to improving international comparisons. Health Topics: Coronavirus Coronavirus Coronavirus Service: Épidémiologie des maladies infectieuses ...
Surveillance épidémiologique de la Varicelle et du Zona- varicella-zoster virus (VZV)- aperçu 2010-2022 et résultats détaillés 2019-2022
1 à 4 ans, suivis des moins d’1 an, furent les plus touchés que ce soit pour les consultations en médecine générale ou pour les hospitalisations. En moyenne 767 hospitalisations par an (diagnostics primaires ...
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.
hospitalisation (VE h), given time since vaccination and prior infection.MethodsNationwide healthcare records from July 2021 to May 2022 on testing and vaccination were combined with a clinical hospital survey. We ...
Social inequalities and long-term health impact of COVID-19 in Belgium: protocol of the HELICON population data linkage
a representative case-cohort study of 1.2 million randomly selected Belgians and 4.5 million Belgians with a confirmed COVID-19 diagnosis (PCR or antigen test), of which 108 211 are COVID-19 hospitalised patients ...
Couverture vaccinale et impact épidémiologique de la campagne de vaccination COVID-19 chez les personnes présentant des maladies sous-jacentes en Belgique
sous-jacentes, la vaccination contre la COVID-19 offre une protection contre une hospitalisation et une admission en USI. Par exemple, au cours de la période de dominance du variant Omicron, la protection initiale ...
Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.
on in-hospital deaths of laboratory-confirmed influenza patients in 11 European Union countries from 2010/11 to 2019/20.MethodsCase-based surveillance data from hospitalised patients with known age, ...